Syros Pharmaceuticals Investors

86 investors on Angel Roster list Syros Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series A and the largest groups are based in the United States, Hong Kong and Israel.

Investors are matched on the company name in their portfolio, so companies that share the name Syros Pharmaceuticals can appear together.

Investors listed
86
With verified email
55%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 Syros Pharmaceuticals investors

The most complete profiles first. Showing 40 of 86.

  • Adam GreeneVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Alex GoldsmithVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Annie MitsakVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Ashish KotechaVerified

    Venture Capital, Private Equity Firm, Investment Partner · India

    SeedHealth CareGeneticsE-commerceWomen Founded

    Portfolio: Invoke Solutions, Evident.io, LaLa Media, INRIX and 80 more

    Verified email available

  • Avak KahvejianVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more

    Verified email available

  • Charles LawsonVerified

    Venture Capital, Private Equity Firm, Investment Partner · Australia

    SeedHealth CareGeneticsE-commerceWomen Founded

    Portfolio: Invoke Solutions, Evident.io, LaLa Media, INRIX and 80 more

    Verified email available

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Ewen CameronVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan ZhuVerified

    Venture Capital, Private Equity Firm, Investment Partner

    Series BSeries AHealth CareGeneticsE-commerceWomen Founded

    Portfolio: Invoke Solutions, Evident.io, LaLa Media, INRIX and 80 more

    Verified email available

  • Mike ChoiVerified

    Venture Capital, Private Equity Firm, Investment Partner

    Series BSeries AHealth CareGeneticsE-commerceWomen Founded

    Portfolio: Invoke Solutions, Evident.io, LaLa Media, INRIX and 80 more

    Verified email available

  • Molly GibsonVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Narendra NayakVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Nicholas BishopVerified

    Hedge Fund, Venture Capital, Investment Partner · United States

    Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information Services

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Nick PlugisVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Pavninder SinghVerified

    Venture Capital, Private Equity Firm, Investment Partner · India

    SeedHealth CareGeneticsE-commerceWomen Founded

    Portfolio: Invoke Solutions, Evident.io, LaLa Media, INRIX and 80 more

    Verified email available

  • Sabrina YangVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Sebastian TrousilVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Stephen BerensonVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Sunny ReddyVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Torben Straight NissenVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Yuji SugimotoVerified

    Venture Capital, Private Equity Firm, Investor · Japan

    Series BHealth CareGeneticsE-commerceWomen Founded

    Portfolio: Invoke Solutions, Evident.io, LaLa Media, INRIX and 80 more

    Verified email available

  • Aftab KheraniVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Andrew PangVerified

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Verified email available

  • Andrew SchiffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more

    Verified email available

  • AnneVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • David HickmanVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Debbie BakerVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Douglas ColeVerified

    Venture Capital, Entrepreneurship Program · United States

    Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Edward HanVerified

    Private Equity Firm · Australia

    Health CareGeneticsE-commerceWomen Founded

    Portfolio: Invoke Solutions, Evident.io, LaLa Media, INRIX and 80 more

    Verified email available

  • Eric AguiarVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Frank YaoVerified

    Private Equity Firm · Hong Kong

    Health CareGeneticsE-commerceWomen Founded

    Portfolio: Invoke Solutions, Evident.io, LaLa Media, INRIX and 80 more

    Verified email available

  • Howie FurstVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Ignacio MartinezVerified

    Venture Capital, Entrepreneurship Program · United States

    Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 52 more

    Verified email available

  • Jim GilbertVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Josh BilenkerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Josh FriedmanVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

See all 86 Syros Pharmaceuticals investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many Syros Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 86 Syros Pharmaceuticals investors. 47 of them (55%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (63), Private Equity Firms (47) and Investment Partner Investors (12). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Syros Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Series A (22), Seed (16) and Series B (9).

Where are Syros Pharmaceuticals investors based?

Most are based in the United States (68), Hong Kong (3) and Israel (2).

Which companies have Syros Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Nuvation Bio (43), Editas Medicine (42), T2 Biosystems (28), Selecta Biosciences (28) and Codiak Biosciences (28).

How do I contact Syros Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 86, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.